Progenesis QI Software Acquisition

The contract involves the acquisition of a single commercial perpetual software license for the Progenesis QI Software. The contractor is responsible for delivering the software along with activation credentials and all necessary commercial documentation. Notably, the contract explicitly excludes system development, hosting services, contractor access to FDA systems, and any ongoing managed services, focusing solely on the software license itself. Issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, the solicitation number for this contract is FDA-75F40126Q00143. The contract is classified under NAICS code 5132 and is designated as a combined type with no set-aside requirements. The place of performance is in Saint Louis, Missouri, while the administrative office is located in Rockville, Maryland. Interested parties were required to respond by May 25, 2026, and the primary contact for this acquisition is Roosevelt Walker, who can be reached via email for further inquiries.